Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study.
Journal: Blood cancer journal
Published: April 15, 2026
Gilteritinib for Prevention of Post-transplant Relapse in Patients With Acute Myeloid Leukemia and FLT3-ITD Mutation: Real-Life Data from Two Centers.
Journal: Transplantation and cellular therapy
Published: February 05, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing with Engineered Immune Effector Cells.
Journal: Transplantation and cellular therapy
Published: January 05, 2026
Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2.
Journal: Blood and lymphatic cancer : targets and therapy
Published: December 02, 2025
Real-World Outcomes of Acute Myeloid Leukemia Patients Undergoing Treatment With Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3, IDH1, or IDH2.
Journal: Cancer reports (Hoboken, N.J.)
Published: October 29, 2025
Case Report: Successful treatment of steroid-refractory graft-vs.-host disease following bilateral lung transplantation.
Journal: Frontiers in transplantation
Published: August 08, 2025
Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee.
Journal: Journal for immunotherapy of cancer
Published: June 09, 2025
Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients.
Journal: Transplantation and cellular therapy
Published: June 04, 2025
Last Updated: 09/26/2026